Is sustained disease control the new benchmark for patient care?
7 October, 10:15 – 11:15 CEST
Forum
Chairperson(s):
C. Hoyng THE NETHERLANDS
Laser for retina and vitreous: All you need to know in 2023.
7 October, 10:15 – 11:15 CEST
Emerald Room
Chairperson(s):
Victor Chong UK
Informed decision-making every step of the way – Part 2: Visualization in vitreoretinal surgery
7 October, 10:15 – 11:15 CEST
E102
Chairperson(s):
J.F. Korobelnik FRANCE
Discovering ChANGe with Ang-2
7 October, 10:15 – 11:15 CEST
E103/104
Chairperson(s):
P. Schlottman ARGENTINA
IME: Dry AMD & GA IME Platform: Practical Considerations for GA Treatment
7 October, 10:15 – 11:15 CEST
Elicium 2
Chairperson(s):
A. Loewenstein ISRAEL,
R. Tadayoni FRANCE
Geographic Atrophy: Navigating to the future
7 October, 13:00 – 14:00 CEST
Elicium 2
Chairperson(s):
R. Tadayoni FRANCE
What is Bayer’s vision for the future of ophthalmology?
7 October, 13:00 – 14:00 CEST
Forum
Chairperson(s):
J.F Korobelnik FRANCE
New Dimensions in Visualization: Changing the Way You Look
7 October, 13:00 – 14:00 CEST
E103/104
Chairperson(s):
R. Rejdak POLAND
High-Resolution OCT in Retinal Disorders including atrophic AMD
7 October, 13:00 – 14:00 CEST
E102
Chairperson(s):
S. Schulz GERMANY
LIGHTSITE III Pivotal Trial 24-Month Analysis: Multiwavelength Valeda® Light Delivery System Treatment in Early/Intermediate Dry Age-Related Macular Degeneration Patients
7 October, 13:00 – 14:00 CEST
Emerald Room
Chairperson(s):
Q.D. Nguyen USA
Retinale® – EURETINA Kompakt
7 October, 18:00 – 19:00 CEST
E103/104
Chairperson(s):
N. Feltgen GERMANY
